News

01 Polsky Center, UChicago 17 June 2026 George Shultz Innovation Fund awards $250K to Parasol Medtech and Signl

The fund selected Signl as one of two University of Chicago startups for investment.

 ↗ 02 ACS Central Science February 2023 Discovery of new states of immunomodulation for vaccine adjuvants via high throughput screening: expanding innate responses to PRRs

Kim JY, Rosenberger MG, Chen S, et al. ACS Cent Sci 2023;9(3):427-439.

 ↗ 03 In the Pipeline, Science Derek Lowe Enhancing the enhancers for vaccines

A write-up of the immunomodulator screening approach.

 ↗ 04 UChicago PME 30 October 2023 Designing the next generation of vaccines

A profile of the compound work behind the company.

 ↗ 05 UChicago PME 19 September 2023 Pritzker School of Molecular Engineering enters academic-industry partnership to create next generation vaccines

On the academic program the technology came out of.

 ↗